PH12012501150A1 - Nutritional compositions and methods for optimizing dietary acid-base potential - Google Patents

Nutritional compositions and methods for optimizing dietary acid-base potential

Info

Publication number
PH12012501150A1
PH12012501150A1 PH1/2012/501150A PH12012501150A PH12012501150A1 PH 12012501150 A1 PH12012501150 A1 PH 12012501150A1 PH 12012501150 A PH12012501150 A PH 12012501150A PH 12012501150 A1 PH12012501150 A1 PH 12012501150A1
Authority
PH
Philippines
Prior art keywords
methods
nutritional compositions
acid
potential
base potential
Prior art date
Application number
PH1/2012/501150A
Other languages
English (en)
Inventor
Douglad Richard Bolster
Norman Alan Greenberg
Jennifer Rae Mager
Kevin Burke Miller
Zamzam Kabiry Roughead
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PH12012501150A1 publication Critical patent/PH12012501150A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mathematical Optimization (AREA)
  • Immunology (AREA)
  • Software Systems (AREA)
  • Databases & Information Systems (AREA)
  • Algebra (AREA)
  • Pure & Applied Mathematics (AREA)
PH1/2012/501150A 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential PH12012501150A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28892809P 2009-12-22 2009-12-22
US29668810P 2010-01-20 2010-01-20
US201061424070P 2010-12-17 2010-12-17
PCT/US2010/061444 WO2011087769A2 (en) 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential

Publications (1)

Publication Number Publication Date
PH12012501150A1 true PH12012501150A1 (en) 2012-10-22

Family

ID=44304885

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/501150A PH12012501150A1 (en) 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential

Country Status (13)

Country Link
US (1) US20130129838A1 (enExample)
EP (1) EP2516007A2 (enExample)
JP (1) JP2013514812A (enExample)
CN (1) CN102753043A (enExample)
AU (1) AU2010341566A1 (enExample)
BR (1) BR112012018321A2 (enExample)
CA (1) CA2785262A1 (enExample)
IN (1) IN2012DN05279A (enExample)
MX (1) MX2012007300A (enExample)
PH (1) PH12012501150A1 (enExample)
RU (1) RU2012131125A (enExample)
SG (1) SG181619A1 (enExample)
WO (1) WO2011087769A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
US20150150898A1 (en) * 2012-06-11 2015-06-04 Nu Science Laboratories, Inc. Nutritional products and methods of improving exercise performance and reducing exercise induced impairment of immune function
CN104780786A (zh) * 2012-09-21 2015-07-15 雅培制药有限公司 包括β-羟基-β-甲基丁酸钙、蛋白质和低水平的电解质的营养组合物
JP6276286B2 (ja) * 2012-12-14 2018-02-07 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルのための老化防止の食品
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
CA2926599C (en) * 2013-11-05 2021-05-04 Hill's Pet Nutrition, Inc. Methods and compositions for improving kidney function
WO2016154575A1 (en) * 2015-03-26 2016-09-29 Cambrooke Therapeutics, Inc. Aqueous ketogenic compositions
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
IT202000008203A1 (it) * 2020-04-17 2021-10-17 D M F Dietetic Metabolic Food S R L Composizione nutrizionale per il trattamento delle malattie metaboliche
WO2025181327A1 (en) 2024-03-01 2025-09-04 Aarhus Universitet Quantification of renal acid-base excretion in people with short bowel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002204A1 (de) * 1990-01-26 1991-08-01 Westfalen Milchwerke Diaetetisches nahrungsmittel fuer patienten mit niereninsuffizienz
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
JP2000264844A (ja) * 1999-01-11 2000-09-26 Otsuka Pharmaceut Factory Inc 腎疾患患者用栄養組成物
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US20090137459A1 (en) * 2005-11-21 2009-05-28 Katry Inversiones, S.L. Food Product for Enteral or Oral Nutrition

Also Published As

Publication number Publication date
WO2011087769A2 (en) 2011-07-21
CN102753043A (zh) 2012-10-24
RU2012131125A (ru) 2014-01-27
MX2012007300A (es) 2012-07-04
WO2011087769A3 (en) 2011-10-27
SG181619A1 (en) 2012-07-30
JP2013514812A (ja) 2013-05-02
AU2010341566A1 (en) 2012-07-12
EP2516007A2 (en) 2012-10-31
CA2785262A1 (en) 2011-07-21
IN2012DN05279A (enExample) 2015-08-07
US20130129838A1 (en) 2013-05-23
BR112012018321A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
PH12012501150A1 (en) Nutritional compositions and methods for optimizing dietary acid-base potential
MX342423B (es) Metodos para usar inhibidores de cotransportadores 1 y 2 de glucosa y sodio.
MX2022004262A (es) Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.
MY165142A (en) Metabolic imprinting effects of specifically designed lipid component
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
MY162091A (en) Infant nutritional compositions for preventing obesity
Dai et al. Association between folate intake, serum folate levels and the risk of lung cancer: a systematic review and meta-analysis
WO2010006026A3 (en) Improving renal function with quercetin-containing compositions
NZ601552A (en) Component display processing method and user equipment
Bleackley et al. Blood iron homeostasis: newly discovered proteins and iron imbalance
UA100394C2 (en) Lipoic acid pellet composition
MY149433A (en) Nutritional compositions containing punicalagins
GB2500847A (en) Timed reading experience electronic book
MY155615A (en) Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
WO2010028336A3 (en) Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
TW200726460A (en) Anti-fatigue composition
MY187748A (en) Compositions and method for maintaining/improving cognitive function
SG123793A1 (en) Low oxygen content alloy compositions
Assmann 111 THE PATIENT AT RISK FOR MYOCARDIAL INFARCTION AND STROKE: NEW PROCAM DATA
Ryu et al. The current status and tasks of technology assessment in Korea
WO2008143879A3 (en) Vitamin e supplementation for reducing cardiovascular events in individuals with dm and the hp 2-2 genotype
WO2010030604A3 (en) Methods and compositions for determining and monitoring dietary supplementation
UA49760U (ru) Способ оценки прогноза продления хронической миелоидной лейкемии по уровню экспрессии cd38 антигена в клетках костного мозга
MD3879F1 (en) Food additive
TW200605875A (en) Dietary compositions for enhancing metabolism and reducing reactive oxygen species